IRME OTC
IR-Med Inc.
1W: +0.0%
1M: +0.0%
3M: -70.0%
YTD: -94.8%
1Y: -95.6%
3Y: -99.6%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$1M
+57.1% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$1M
+57.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$638K
+71.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$752K | -$4M | -$5M | -$5M | -$2M |
| Depreciation & Amort. | $1K | $5K | $10K | $17K | $21K |
| Stock-Based Comp. | $25K | $1M | $1M | $2M | $485K |
| Change in Working Capital | $304K | -$121K | $47K | -$25K | $5K |
| Other Non-Cash Items | $45K | $11K | -$28K | $58K | $2K |
| Operating Cash Flow | -$402K | -$2M | -$3M | -$3M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$31K | -$50K | -$2K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$30K | -$9K | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$30K | -$9K | $0 | $0 |
| Investing Cash Flow | $0 | -$61K | -$59K | -$2K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | -$5K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $1M | $0 |
| Financing Cash Flow | $2M | $3M | $4M | $1M | $750K |
| Net Change in Cash | $2M | $949K | $187K | -$2M | -$638K |
| Cash End of Period | $2M | $3M | $3M | $767K | $129K |
| Free Cash Flow | -$402K | -$3M | -$3M | -$3M | -$1M |